|
HRP20230747T1
(hr)
|
2011-09-08 |
2024-01-05 |
Sage Therapeutics, Inc. |
Neuroaktivni steroidi, pripravci i njihova uporaba
|
|
CN119192266A
(zh)
|
2011-10-14 |
2024-12-27 |
萨奇治疗股份有限公司 |
3,3-二取代的19-去甲孕甾烷化合物、组合物、及其用途
|
|
SG10201606063RA
(en)
|
2012-01-23 |
2016-09-29 |
Sage Therapeutics Inc |
Neuroactive steroid formulations and methods of treating cns disorders
|
|
MX2015002252A
(es)
|
2012-08-21 |
2015-07-21 |
Sage Therapeutics Inc |
Metodos para tratar epilepsia o estado de epilepsia.
|
|
DK2925327T3
(da)
|
2012-11-30 |
2024-03-25 |
Univ California |
Allopregnanolon til behandling, reduktion eller lindring af symptomer på fødselsdepression
|
|
SMT201800657T1
(it)
|
2013-03-13 |
2019-01-11 |
Sage Therapeutics Inc |
Steroidi neuroattivi e loro metodi di utilizzo
|
|
WO2014169831A1
(en)
|
2013-04-17 |
2014-10-23 |
Sage Therapeutics, Inc. |
19-nor c3,3-disubstituted c21-c-bound heteroaryl steroids and methods of use thereof
|
|
JP6470258B2
(ja)
|
2013-04-17 |
2019-02-13 |
セージ セラピューティクス， インコーポレイテッド |
１９−ノルｃ３，３−ジ置換ｃ２１−ｎ−ピラゾリルステロイドおよびその使用方法
|
|
ES2807264T3
(es)
|
2013-04-17 |
2021-02-22 |
Sage Therapeutics Inc |
Esteroides neuroactivos 19-nor para métodos de tratamiento
|
|
WO2014169836A1
(en)
|
2013-04-17 |
2014-10-23 |
Sage Therapeutics, Inc. |
19-nor neuroactive steroids and methods of use thereof
|
|
WO2015010054A2
(en)
|
2013-07-19 |
2015-01-22 |
Sage Therapeutics, Inc. |
Neuroactive steroids, compositions, and uses thereof
|
|
ES2848823T3
(es)
|
2013-08-23 |
2021-08-12 |
Sage Therapeutics Inc |
Esteroides neuroactivos, composiciones y usos de los mismos
|
|
WO2015195967A1
(en)
|
2014-06-18 |
2015-12-23 |
Sage Therapeutics, Inc. |
Oxysterols and methods of use thereof
|
|
WO2015195962A1
(en)
|
2014-06-18 |
2015-12-23 |
Sage Therapeutics, Inc. |
Neuroactive steroids, compositions, and uses thereof
|
|
MA40498A
(fr)
|
2014-09-02 |
2021-05-19 |
Texas A & M Univ Sys |
Méthode de traitement de l'intoxication par organophosphates
|
|
JOP20200195A1
(ar)
|
2014-09-08 |
2017-06-16 |
Sage Therapeutics Inc |
سترويدات وتركيبات نشطة عصبياً، واستخداماتها
|
|
US10577390B2
(en)
|
2014-10-16 |
2020-03-03 |
Sage Therapeutics, Inc. |
Compositions and methods for treating CNS disorders
|
|
ME03809B
(me)
|
2014-10-16 |
2021-04-20 |
Sage Therapeutics Inc |
KOMPOZICIJE I POSTUPCI ZA LEČENJE POREMEĆAJA CNS-a
|
|
WO2016082789A1
(en)
|
2014-11-27 |
2016-06-02 |
Sage Therapeutics, Inc. |
Compositions and methods for treating cns disorders
|
|
WO2016123056A1
(en)
*
|
2015-01-26 |
2016-08-04 |
Sage Therapeutics, Inc. |
Compositions and methods for treating cns disorders
|
|
EP4155314A1
(en)
|
2015-02-20 |
2023-03-29 |
Sage Therapeutics, Inc. |
Neuroactive steroids, compositions, and uses thereof
|
|
MX382122B
(es)
|
2015-07-06 |
2025-03-13 |
Sage Therapeutics Inc |
Oxiesteroles y metodos de uso de los mismos.
|
|
AU2016289965B2
(en)
|
2015-07-06 |
2021-09-09 |
Sage Therapeutics, Inc. |
Oxysterols and methods of use thereof
|
|
PL3319611T3
(pl)
|
2015-07-06 |
2021-07-12 |
Sage Therapeutics, Inc. |
Oksysterole i sposoby ich stosowania
|
|
HK1258616A1
(zh)
*
|
2016-03-08 |
2019-11-15 |
Sage Therapeutics, Inc. |
神经活性类固醇、组合物、及其用途
|
|
EP3436022B1
(en)
|
2016-04-01 |
2022-03-09 |
Sage Therapeutics, Inc. |
Oxysterols and methods of use thereof
|
|
US10752653B2
(en)
|
2016-05-06 |
2020-08-25 |
Sage Therapeutics, Inc. |
Oxysterols and methods of use thereof
|
|
WO2018009867A1
(en)
|
2016-07-07 |
2018-01-11 |
Sage Therapeutics, Inc. |
Oxysterols and methods of use thereof
|
|
US20190233465A1
(en)
|
2016-07-11 |
2019-08-01 |
Sage Therapeutics, Inc. |
C7, c12, and c16 substituted neuroactive steroids and their methods of use
|
|
MA45599A
(fr)
*
|
2016-07-11 |
2019-05-15 |
Sage Therapeutics Inc |
Stéroïdes neuroactifs substitués en c17, c20 et c21 et leurs procédés d'utilisation
|
|
TWI904593B
(zh)
|
2016-08-23 |
2025-11-11 |
美商賽吉醫療公司 |
結晶19-去甲c3,3-二取代之c21-n-吡唑類固醇
|
|
PT3519422T
(pt)
|
2016-09-30 |
2022-12-05 |
Sage Therapeutics Inc |
Oxisteróis substituídos em c7 e métodos como moduladores nmda
|
|
DK4105223T3
(da)
|
2016-10-18 |
2025-07-07 |
Sage Therapeutics Inc |
Oxysteroler og fremgangsmåder til anvendelse deraf
|
|
CA3041088C
(en)
|
2016-10-18 |
2024-05-21 |
Sage Therapeutics, Inc. |
Oxysterols and methods of use thereof
|
|
CN114656514B
(zh)
*
|
2018-02-11 |
2024-05-14 |
江苏豪森药业集团有限公司 |
一种甾族类衍生物调节剂及其制备方法和应用
|
|
EP3750909B1
(en)
*
|
2018-02-11 |
2025-03-05 |
Jiangsu Hansoh Pharmaceutical Group Co., Ltd. |
Steroid derivative regulators, method for preparing the same, and uses thereof
|
|
CR20240234A
(es)
|
2019-05-31 |
2024-07-09 |
Sage Therapeutics Inc |
ESTEROIDES NEUROACTIVOS Y COMPOSICIONES DE ESTOS (Divisional 2021-629)
|
|
US12215126B2
(en)
*
|
2020-05-21 |
2025-02-04 |
Brigham Young University |
Cationic steroidal antimicrobial compounds with endogenous groups
|
|
WO2023060067A1
(en)
|
2021-10-04 |
2023-04-13 |
Marinus Pharmaceuticals, Inc. |
Amorphous solid dispersion ganaxolone formulation
|